0
0
40 words
0
Comments
A new study published in The Lancet suggests that intravenous ferric derisomaltose administration was linked to lower risk of heart failure hospital admissions and cardiovascular death for a wide...
You are the first to view
https://medicaldialogues.in/cardiology-ctvs/news/intravenous-ferric-derisomaltose-reduces-risk-of-heart-failure-lancet-103233
Create an account or login to join the discussion